Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis

被引:146
作者
Hatzi, Katerina [1 ,2 ]
Melnick, Ari [1 ,2 ]
机构
[1] Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA
关键词
transcriptional repression; lymphomagenesis; gene enhancers; epigenetic regulation; BCL6; transcription factor targeted therapy; CENTER B-CELL; TRANSCRIPTION FACTOR; LYMPHOCYTE DIFFERENTIATION; GENE-EXPRESSION; ONCOGENE BCL6; IN-VITRO; KAPPA-B; REPRESSION; COREPRESSOR; INHIBITOR;
D O I
10.1016/j.molmed.2014.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The B cell lymphoma 6 (BCL6) transcriptional repressor is a master regulator of the germinal center (GC) B cell program, required for their unique proliferative and stress tolerant phenotype. Most B cell lymphomas arise from GC B cells and are dependent on the continued or deregulated expression of BCL6 to maintain their survival. The actions of BCL6 in B cells involve formation of distinct chromatin modifying complexes that silence specific promoter and enhancer networks, respectively. The same biochemical mechanisms are maintained in malignant lymphoma cells. Targeted inhibition of these BCL6 functions has emerged as the basis for rational design of lymphoma therapies and combinatorial regimens. In this review, we summarize recent advances on BCL6 mechanisms of action and the deregulation of its target gene networks in lymphoma.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 76 条
[1]   Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain [J].
Ahmad, KF ;
Melnick, A ;
Lax, S ;
Bouchard, D ;
Liu, J ;
Kiang, CL ;
Mayer, S ;
Takahashi, S ;
Licht, JD ;
Privé, GG .
MOLECULAR CELL, 2003, 12 (06) :1551-1564
[2]   Germinal-center organization and cellular dynamics [J].
Allen, Christopher D. C. ;
Okada, Takaharu ;
Cyster, Jason G. .
IMMUNITY, 2007, 27 (02) :190-202
[3]   The human BCL6 transgene promotes the development of lymphomas in the mouse [J].
Baron, BW ;
Anastasi, J ;
Montag, A ;
Huo, DZ ;
Baron, RM ;
Karrison, T ;
Thirman, MJ ;
Subudhi, SK ;
Chin, RK ;
Felsher, DW ;
Fu, YX ;
McKeithan, TW ;
Baron, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (39) :14198-14203
[4]   BCL6 positively regulates AID and germinal center gene expression via repression of miR-155 [J].
Basso, Katia ;
Schneider, Christof ;
Shen, Qiong ;
Holmes, Antony B. ;
Setty, Manu ;
Leslie, Christina ;
Dalla-Favera, Riccardo .
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (13) :2455-2465
[5]   Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice [J].
Cattoretti, G ;
Pasqualucci, L ;
Ballon, G ;
Tam, W ;
Nandula, SV ;
Shen, Q ;
Mo, TW ;
Murty, VV ;
Dalla-Favera, R .
CANCER CELL, 2005, 7 (05) :445-455
[6]   BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS [J].
CATTORETTI, G ;
CHANG, CC ;
CECHOVA, K ;
ZHANG, JD ;
YE, BH ;
FALINI, B ;
LOUIE, DC ;
OFFIT, K ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1995, 86 (01) :45-53
[7]   Sequential transcription factor targeting for diffuse large B-Cell lymphomas [J].
Cerchietti, Leandro C. ;
Polo, Jose M. ;
Da Silva, Gustavo F. ;
Farinha, Pedro ;
Shaknovich, Rita ;
Gascoyne, Randy D. ;
Dowdy, Steven F. ;
Melnick, Ari .
CANCER RESEARCH, 2008, 68 (09) :3361-3369
[8]   BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy [J].
Cerchietti, Leandro C. ;
Hatzi, Katerina ;
Caldas-Lopes, Eloisi ;
Yang, Shao Ning ;
Figueroa, Maria E. ;
Morin, Ryan D. ;
Hirst, Martin ;
Mendez, Lourdes ;
Shaknovich, Rita ;
Cole, Philip A. ;
Bhalla, Kapil ;
Gascoyne, Randy D. ;
Marra, Marco ;
Chiosis, Gabriela ;
Melnick, Ari .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (12) :4569-4582
[9]   A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo [J].
Cerchietti, Leandro C. ;
Ghetu, Alexandru F. ;
Zhu, Xiao ;
Da Silva, Gustavo F. ;
Zhong, Shijun ;
Matthews, Marilyn ;
Bunting, Karen L. ;
Polo, Jose M. ;
Fares, Christophe ;
Arrowsmith, Cheryl H. ;
Yang, Shao Ning ;
Garcia, Monica ;
Coop, Andrew ;
MacKerell, Alexander D., Jr. ;
Prive, Gilbert G. ;
Melnick, Ari .
CANCER CELL, 2010, 17 (04) :400-411
[10]   A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas [J].
Cerchietti, Leandro C. ;
Lopes, Eloisi C. ;
Yang, Shao Ning ;
Hatzi, Katerina ;
Bunting, Karen L. ;
Tsikitas, Lucas A. ;
Mallik, Alka ;
Robles, Ana I. ;
Walling, Jennifer ;
Varticovski, Lyuba ;
Shaknovich, Rita ;
Bhalla, Kapil N. ;
Chiosis, Gabriela ;
Melnick, Ari .
NATURE MEDICINE, 2009, 15 (12) :1369-U3